US Patent 11352350 IRAK degraders and uses thereof
Patent 11352350 was granted and assigned to Kymera Therapeutics on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Arthur F. Kluge0
Matthew M. Weiss0
Nan Ji0
Nello Mainolfi0
Xiaozhang Zheng0
Yi Zhang0
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113523500
Date of Patent
June 7, 2022
0Patent Application Number
167010770
Date Filed
December 2, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+94 characters)
US Patent 11352350 IRAK degraders and uses thereof
Article
The present invention provides compounds, compositions thereof, and methods of using the same.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11352350
Date of patent
June 7, 2022
Patent application number
16701077
Date Filed
December 2, 2019
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11352350 IRAK degraders and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
